| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/28/2011 | US20110098295 Methods of treating anxiety, itching and psychiatric disorders |
| 04/28/2011 | US20110098294 Purine analogs |
| 04/28/2011 | US20110098293 Inhibitors of Protein Tyrosine Kinase Activity |
| 04/28/2011 | US20110098292 New Compounds Useful for Treating CNS Disorders |
| 04/28/2011 | US20110098291 Antagonist of smoothened |
| 04/28/2011 | US20110098290 Pharmaceutical compounds |
| 04/28/2011 | US20110098289 Method for treating obesity |
| 04/28/2011 | US20110098288 Sulfonamides as zap-70 inhibitors |
| 04/28/2011 | US20110098286 (3-aryl-piperazin-1-yl), (2-aryl-morpholin-4-yl) and (2-aryl-thiomorpholin-4-yl) derivatives of 6,7-dialkoxy-quinazoline, 6,7-dialkoxyphtalazine and 6,7-dialkoxyisoquinoline |
| 04/28/2011 | US20110098285 Bicyclic-substituted amines as histamine-3 receptor ligands |
| 04/28/2011 | US20110098284 Methods and compositions for treating pain |
| 04/28/2011 | US20110098283 3-cinnolinecarboxamide derivatives and their use for treating cancer |
| 04/28/2011 | US20110098282 New compounds |
| 04/28/2011 | US20110098281 Benzenesulfonyl Compounds and the Use Thereof |
| 04/28/2011 | US20110098280 2,4-pyrimidinediamines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders |
| 04/28/2011 | US20110098278 Galantamine amino acid and peptide prodrugs and uses thereof |
| 04/28/2011 | US20110098277 Fab I Inhibitors |
| 04/28/2011 | US20110098276 Oxycarbamoyl compounds and the use thereof |
| 04/28/2011 | US20110098275 5-alkynyl-pyridines |
| 04/28/2011 | US20110098274 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors |
| 04/28/2011 | US20110098273 Oligomer-Calcium Channel Blocker Conjugates |
| 04/28/2011 | US20110098272 Novel Compounds As Casein Kinase Inhibitors |
| 04/28/2011 | US20110098271 Chromenone derivatives |
| 04/28/2011 | US20110098270 Thiazolopyrimidines and their use as inhibitors of phosphatidylinositol-3 kinase |
| 04/28/2011 | US20110098269 Substituted Pyridazinone Derivatives as Histamine-3 (H3) Receptor Ligands |
| 04/28/2011 | US20110098268 Spirocyclic compounds |
| 04/28/2011 | US20110098267 Topical formulations for the treatment of psoriasis |
| 04/28/2011 | US20110098266 Method of administering an injectable antibiotic to an animal |
| 04/28/2011 | US20110098265 Methods for reducing cravings and impulses associated with addictive and compulsive behaviors |
| 04/28/2011 | US20110098264 Pharmaceutical composition containing cyclometalated n-heterocyclic carbene complexes for cancer treatment |
| 04/28/2011 | US20110098263 Hydroxy-substituted cold(iii) porphyrin complexes as histone deacetylase inhibitors |
| 04/28/2011 | US20110098262 Corroles for neuroprotection and neurorescue |
| 04/28/2011 | US20110098261 Triterpenoid-based compounds useful as virus inhibitors |
| 04/28/2011 | US20110098260 Steroid Compounds and Formulations |
| 04/28/2011 | US20110098259 Pregnane steroids and their use in the treatment of cns disorders |
| 04/28/2011 | US20110098258 Transdermal Pharmaceutical Compositions Comprising Active Agents |
| 04/28/2011 | US20110098257 Derivatives of 4- or 5-aminosalicylic acid |
| 04/28/2011 | US20110098256 Method for making and using a topical dermatological solution |
| 04/28/2011 | US20110098255 Combination of a parp inhibitor and an akt kinase activating compound |
| 04/28/2011 | US20110098254 Compositions comprising phospholipids |
| 04/28/2011 | US20110098253 Nitrosated Nonsteroidal Antiinflammatory Compounds, Compositions and Methods of Use |
| 04/28/2011 | US20110098252 Treatment of Spinal Mechanical Pain |
| 04/28/2011 | US20110098251 Bisphosphonate compounds |
| 04/28/2011 | US20110098250 Water-soluble benzoazepine compound and its pharmaceutical composition |
| 04/28/2011 | US20110098249 Compositions and methods of treatment for alleviating premenstrual syndrome symptoms |
| 04/28/2011 | US20110098248 Modulators of toll-like receptors |
| 04/28/2011 | US20110098247 Substituted Dihydroquinazolines as Platelet ADP Receptor Inhibitors |
| 04/28/2011 | US20110098246 Method for preventing corticosteroid usage |
| 04/28/2011 | US20110098245 Agent for preventing or ameliorating obesity |
| 04/28/2011 | US20110098244 Process for Isolating Sialic Acid Containing Oligosaccharides, and the Compositions Containing Sialic Acid Containing Oligosaccharides Obtainable Thereby |
| 04/28/2011 | US20110098243 Ectonucleotidase pyrophosphate/phosphodiesterase-1 (enpp-1) as a target for the treatment of aortic valve stenosis and cardiovascular calcification |
| 04/28/2011 | US20110098242 Methods and Compositions for Diagnosing and Treating Cervical Intraepithelial Neoplasia and Cervical Cancer |
| 04/28/2011 | US20110098241 Rapamycin analogs as anti-cancer agents |
| 04/28/2011 | US20110098240 Pharmaceutical composition comprising a sglt2 inhibitor in combination with a dpp-iv inhibitor |
| 04/28/2011 | US20110098239 Novel diaryl hepatonoid-based compounds and use thereof |
| 04/28/2011 | US20110098238 Elucidating ligand-binding information based on protein templates |
| 04/28/2011 | US20110098237 Methods for inhibiting drug degradation |
| 04/28/2011 | US20110098236 Diamide inhibitors of cytochrome p450 |
| 04/28/2011 | US20110098233 Hla-a* 1101-restricted wt1 peptide and pharmaceutical composition comprising the same |
| 04/28/2011 | US20110098229 Compositions and methods for treating dermatological conditions |
| 04/28/2011 | US20110098221 INHIBITORS OF Akt ACTIVITY |
| 04/28/2011 | US20110098219 System for Curing Hepatic Cancer with Leptin |
| 04/28/2011 | US20110098212 Cytokine |
| 04/28/2011 | US20110097794 Whitefly Ecdysone Receptor Nucleic Acids, Polypeptides, and Uses Thereof |
| 04/28/2011 | US20110097726 Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene |
| 04/28/2011 | US20110097426 Methods for Safe and Effective Treatment Using Oxazaphosphorine Drugs |
| 04/28/2011 | US20110097420 Cement products and methods of making and using the same |
| 04/28/2011 | US20110097419 Poly(Propargyl-L-Glutamate) and Derivatives Thereof |
| 04/28/2011 | US20110097414 Pharmaceutical compositions comprising adsorbate of fenofibrate |
| 04/28/2011 | US20110097413 Solid state forms of deferasirox salts and process for the preparation thereof |
| 04/28/2011 | US20110097412 Methods of treatment of endobronchial infections |
| 04/28/2011 | US20110097410 Formulations of px compounds |
| 04/28/2011 | US20110097409 Particles comprising a salt of 8-hydroxy-2-[[(1r)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]-2(1h)-quinolinone having improved adhesion properties for powder formulations for inhalation |
| 04/28/2011 | US20110097407 Butenafine Hydrochloride-Containing Aqueous Patch |
| 04/28/2011 | US20110097405 Estradiol-containing drug delivery system |
| 04/28/2011 | US20110097404 Tamper-resistant oral opioid agonist formulations |
| 04/28/2011 | US20110097402 Non-adhesive elastic gelatin matrices |
| 04/28/2011 | US20110097401 Methods for treating gastrointestinal disorders |
| 04/28/2011 | US20110097399 Fast dissolving/disintegrating coating compositions |
| 04/28/2011 | US20110097396 Peeling capsule with integrated care effect |
| 04/28/2011 | US20110097395 Oral Pharmaceutical Compositions of Buprenorphine and Method of Use |
| 04/28/2011 | US20110097394 Type a gelatin capsule containing pufa in free acid form |
| 04/28/2011 | US20110097393 Skin Patches and Sustained-Release Formulations Comprising Lofexidine for Transdermal and Oral Delivery |
| 04/28/2011 | US20110097391 Phospholipid Emulsion Containing Dihydroquercetin, and Method of Producing Thereof |
| 04/28/2011 | US20110097390 Ultra-Small RNAs as Toll-Like Receptor-3 Antagonists |
| 04/28/2011 | US20110097387 Particulate drug carriers as desensitizing agents |
| 04/28/2011 | US20110097385 Delivery System for Drug and Cell Therapy |
| 04/28/2011 | US20110097384 Transdermal drug delivery device including an occlusive backing |
| 04/28/2011 | US20110097380 Clonidine formulations having antimicrobial properties |
| 04/28/2011 | US20110097379 Directed stem cell recruitment |
| 04/28/2011 | US20110097377 Methods and Devices for Correcting Spinal Deformity With Pharmaceutical-Eluting Pedicle Screws |
| 04/28/2011 | US20110097375 Formulation for preventing or reducing bleeding at a surgical site |
| 04/28/2011 | US20110097372 Devices, methods, and compositions for controlling infections |
| 04/28/2011 | US20110097367 Monolithic in-situ cross-linked alginate implants |
| 04/28/2011 | US20110097364 Macrocyclic lactone compounds and methods for their use |
| 04/28/2011 | US20110097362 Transmucosal Administration of Aggregated Antigens |
| 04/28/2011 | US20110097352 Inducing cellular immune responses to hepatitis B virus using peptide and nucleic acid compositions |
| 04/28/2011 | US20110097350 Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis |
| 04/28/2011 | US20110097349 Phosphoinositide 3-kinase inhibitor compounds and methods of use |
| 04/28/2011 | US20110097347 Niacin compositions for reduction of amyloid beta peptide 42 (abeta 42) production and for treatment of alzheimer's disease (ad) |